Contact Our Sales Team
Built to support real-world healthcare AI workloads
Vultr democratizes cloud and AI with a flexible, open software ecosystem and composable infrastructure, offering healthcare organizations choice, agility, and cost-efficiency.
Vultr Cloud GPU for healthcare
Run AI workloads at scale with NVIDIA GPUs available in every Vultr region — supporting diagnostics, genomics, and real-time care while keeping data in-region for compliance.
NVIDIA HGX B200, GH200 Grace Hopper™ Superchip, HGX H100, HGX A100, and more.
Data residency and compliance
Meet HIPAA and other regulatory requirements with in-region data processing, on-demand data sovereignty, and enterprise-grade controls — ensuring sensitive healthcare data stays compliant, secure, and within jurisdictional boundaries at all times.
Composable, end-to-end AI infrastructure
Build what you need — from model training to inference—by integrating Kubernetes, storage, and compute with full API support and no vendor lock-in.
Best price-to-performance
across 32 global regions
Vultr delivers enterprise-grade AI infrastructure with transparent, predictable pricing — helping healthcare teams scale AI without overpaying.
Modernize patient services with AI-powered healthcare NVIDIA NIM on Vultr
Run NVIDIA NIM microservices on Vultr — optimized for healthcare and life sciences. Power AI agents for lab results and clinical document retrieval with agentic AI, real-time insights, and compliance-ready infrastructure, accelerated by NVIDIA HGX B200 and NetApp.
AI use cases that make a difference
Vultr and NVIDIA provide a cloud-based infrastructure that’s ready to support healthcare workloads, from diagnostics and research to real-time data processing.
GenAI Applications
Use pre-trained models to assist with documentation, clinical summaries, and support chat.
Scalable Inference
Run multimodal AI (text, image, audio) to support diagnostics and patient service.
AI Agents for Ops
Automate intake, claims processing, or internal workflows using your existing data.
Real results from the field
Explore how leading healthcare organizations, equipped with the right tools and infrastructure, achieve security, connectivity, and efficiency with Vultr's cloud solutions.
Genomics
Athos Therapeutics runs AI models on Vultr Cloud GPUs to identify treatments for autoimmune diseases and cancer — improving speed and targeting.
Drug discovery
ImmunoPrecise Antibodies (IPA) accelerated its antibody modeling pipeline using Vultr Kubernetes and NVIDIA GPUs, reducing compute costs by 66%.
Telemedicine
Medidex delivers secure, cost-effective virtual care and medication management using Vultr’s HIPAA-ready cloud infrastructure
Healthcare providers
Manage EHRs, process diagnostics, and handle peak loads with reliable infrastructure that scales.
Medical research
Support large-scale data analysis, from clinical trials to population health studies.
Medical devices, equipment
Enable real-time diagnostics and monitoring with edge AI and connected systems.
“Athos is committed to providing novel precision therapeutics for patients with autoimmune diseases and cancer. The combination of Vultr Cloud GPU, accelerated by NVIDIA, and Dell infrastructure enables us to achieve our aims. Our AI computational teams are excited about collaborating with Vultr”
Dimitrios Iliopoulos, PhD MBA, President and CEO, Athos
“Vultr has been more than just a cloud provider for us – they’ve been a true innovation partner. Their HIPAA-compliant solutions and scalable infrastructure have allowed us to focus on what matters most: making healthcare more accessible and user-friendly for everyone.”
Simon Greenberg, Product Manager at Medidex
“LENSai, powered by Vultr’s high-performance cloud, accelerates therapeutic discovery by enabling AI-driven antibody development. Using our proprietary HYFT Indexer and its universal biological fingerprints, we integrate sequence, structure, and function to rapidly generate insights with precision and efficiency, bringing next-generation treatments to life faster than ever.”
Frédéric Chabot, Head of Corporate Development at ImmunoPrecise Antibodies